BDBM2241 US8507533, 136

SMILES CCC[C@@H](Nc1ccc(nc1)-n1cc(cn1)C(C)(C)C)c1ccc(cc1)C(=O)NCCC(O)=O

InChI Key InChIKey=MNXYURVTSFMFCH-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 2241   

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM2241(US8507533, 136)
Affinity DataKi:  30.2nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent